Join CLL Global founder, Dr. Michael Keating, along with our president, Dr. William Wierda, and grant recipient, Dr. Philip Thompson, to hear the latest updates on CLL research and clinical trials and to learn how CLL Global is investing in a brighter future for all CLL patients.